Published by Josh White on 19th June 2019
(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of patient recruitment for the first European phase 3 study of MED2005, 'FM57', on Wednesday, adding that it remained on track to deliver headline data by the end of 2019.
URL: http://www.digitallook.com/dl/news/story/29188214/...